背景:Faecalibacterium prausnitzii(Fp)是一种具有抗炎和免疫调节作用的肠道共生菌,研究发现结直肠癌患者肠道内Fp数量明显减少,可能与肿瘤发生有关。目的:探讨Fp及其基因组DNA(fDNA)干预对外周血单个核细胞(PBMCs)对人结肠癌LoVo细胞杀伤活性的影响及其免疫学机制。方法:将Fp、fDNA或酶解fDNA(d-fDNA)与分离自健康成人的PBMCs体外共培养,MTT实验检测PBMCs对LoVo细胞的杀伤活性,ELISA法检测PBMCs培养上清液中的Th1、Th2型细胞因子干扰素-γ(IFN-γ)、白细胞介素-4(IL-4)含量,real-time PCR检测PBMCs Th1、Th2特异性转录因子T-bet、GATA3表达。结果:与未予干预的PBMCs相比,fDNA干预能显著增强PBMCs对LoVo细胞的杀伤活性(P〈0.05),同时促进PBMCs的IFN-γ分泌和T-bet mRNA表达(P〈0.05),抑制IL-4分泌和GATA3mRNA表达(P〈0.05)。Fp和d-fDNA均未显示出上述作用。结论:fDNA能增强PBMCs对人结肠癌细胞的杀伤活性,其机制可能与上调Th1型免疫应答有关。
Background: Faecalibacterium prausnitzii (Fp) is a commensal intestinal bacterium that exhibits anti-inflammatory and immunomodulatory capacity in vivo and in vitro. It has been reported that Fp in intestinal lumen was reduced in patients with colorectal cancer, which might be a factor associated with cancer development. Aims: To investigate the effect and immunological mechanism of Fp and its genomic DNA (fDNA) on the killing activity of peripheral blood mononuclear cells (PBMCs) against human colon cancer LoVo cells. Methods: PBMCs derived from healthy adults were co-cultured in vitro with Fp, fDNA, or the digested fDNA (d-fDNA), respectively. Killing activity of PBMCs against LoVo cells was measured by MTY assay; concentrations of interferon-gamma ( INF-γ), a Thl-type cytokine and interleukin-4 ( IL-4), a Th2-type cytokine in culture supernatant of PBMCs were determined by ELISA; and expressions of T-bet and GATA3, the transcription factors specific for Thl and Th2 cells, were measured by real-time PCR. Results: Compared with the PBMCs not treated, fDNA could significantly enhance the killing activity of PBMCs against LoVo cells (P 〈 0.05) ; meanwhile, it promoted IFN-γ secretion, upregulated T-bet mRNA expression and inhibited IL-4 secretion and GATA3 mRNA expression in PBMCs (P 〈 0.05). Similar effects were not observed in PBMCs treated with Fp and d-fDNA. Conclusions: fDNA enhances the killing activity of PBMCs against human colon cancer cells by upregulating Thl immune response.